Yildirim OA - Search Results

1

Nivolumab-Related Dry Mouth and Dry Eye: Cross-Sectional Study.

Yildirim OA, Poyraz K, Erdur E, Can C, Gundogan C, Guzel Y, Etem H, Kömek H. Yildirim OA, et al. Cancer Invest. 2021 Nov;39(10):797-807. doi: 10.1080/07357907.2021.1971241. Epub 2021 Sep 22. Cancer Invest. 2021. PMID: 34415812

2

Correlations between whole body volumetric parameters of ⁶⁸Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients.

Yildirim ÖA, Gündoğan C, Can C, Poyraz K, Erdur E, Kömek H. Yildirim ÖA, et al. Ann Nucl Med. 2021 May;35(5):540-548. doi: 10.1007/s12149-021-01594-8. Epub 2021 Feb 14. Ann Nucl Med. 2021. PMID: 33586097

3

Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays.

Yildirim OA, Poyraz K, Erdur E. Yildirim OA, et al. Qual Life Res. 2021 Jul;30(7):1903-1912. doi: 10.1007/s11136-021-02795-4. Epub 2021 Feb 26. Qual Life Res. 2021. PMID: 33635508 Free PMC article.

4

Role of ⁶⁸Ga-PSMA PET/CT parameters in treatment evaluation and survival prediction in prostate cancer patients compared with biochemical response assessment.

Can C, Gündoğan C, Yildirim OA, Poyraz K, Güzel Y, Kömek H. Can C, et al. Among authors: yildirim oa. Hell J Nucl Med. 2021 Jan-Apr;24(1):25-35. doi: 10.1967/s002449912303. Epub 2021 Apr 20. Hell J Nucl Med. 2021. PMID: 33866336 Free article.

5

⁶⁸Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the ¹⁸F-FDG PET/CT.

Kömek H, Can C, Güzel Y, Oruç Z, Gündoğan C, Yildirim ÖA, Kaplan İ, Erdur E, Yıldırım MS, Çakabay B. Kömek H, et al. Among authors: yildirim oa. Ann Nucl Med. 2021 Jun;35(6):744-752. doi: 10.1007/s12149-021-01616-5. Epub 2021 May 2. Ann Nucl Med. 2021. PMID: 33934311

6

The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features.

Erdur E, Yildirim OA, Poyraz K, Aslan F, Yıldız F, Kömek H. Erdur E, et al. Among authors: yildirim oa. Postgrad Med. 2021 Aug;133(6):694-700. doi: 10.1080/00325481.2021.1934493. Epub 2021 Jun 1. Postgrad Med. 2021. PMID: 34030576

7

Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.

Gündoğan C, Kömek H, Can C, Yildirim ÖA, Kaplan İ, Erdur E, Poyraz K, Güzel Y, Oruç Z, Çakabay B. Gündoğan C, et al. Among authors: yildirim oa. Nucl Med Commun. 2022 Jan 1;43(1):64-72. doi: 10.1097/MNM.0000000000001489. Nucl Med Commun. 2022. PMID: 34661379

8

Roles of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET/CT, CA19-9 levels, and complete blood count parameters in predicting survival in patients with unresectable or metastatic pancreatic cancer.

Erdur E, Guzel Y, Yildirim OA, Poyraz K, Yildirim MS, Kaplan H. Erdur E, et al. Among authors: yildirim oa. Ann Ital Chir. 2022;93:85-95. Ann Ital Chir. 2022. PMID: 35166229

9

Medical Oncology or Surgical Oncology: Which Branch Should Be Started in Esophageal Cancer Diagnostic Evaluation?

Yıldırım ÖA, Erdur E. Yıldırım ÖA, et al. Cureus. 2022 Feb 16;14(2):e22286. doi: 10.7759/cureus.22286. eCollection 2022 Feb. Cureus. 2022. PMID: 35350502 Free PMC article.

10

Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study.

İlhan A, Gurler F, Yilmaz F, Seyran E, Bastug V, Gorgulu B, Eraslan E, Yıldırım ÖA, Yazici O, Çakmak Öksüzoğlu ÖB. İlhan A, et al. Among authors: yildirim oa. Cureus. 2023 Mar 2;15(3):e35710. doi: 10.7759/cureus.35710. eCollection 2023 Mar. Cureus. 2023. PMID: 36875256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters